In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 6, 1997, Pages 881-883

  Loo, Vivian G ^a,b   Fallone, Carlo A ^a   De Souza, Edwige ^a   Lavallée, Jocelyne ^a   Barkun, Alan N ^a  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMPICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; DILUTION; DUODENUM ULCER; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DUODENAL ULCER; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; OMEPRAZOLE; QUEBEC;

EID: 0031437541     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.6.881     Document Type: Article

References (10)

1. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. (1994). Helicobacter pylori in peptic ulcer disease. Journal of the American Medical Association 272, 65-9.
2. Soll, A. H. (1996). Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Journal of the American Medical Association 275, 622-9.
3. Noach, L. A., Langenberg, W. L., Bertola, M. A., Dankert, J. & Tytgat G. N. (1994). Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scandinavian Journal of Infectious Diseases 26, 321-7.
4. Jerris, R. C. (1995). Helicobacter. In Manual of Clinical Microbiology, 6th edn (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 492-8. American Society for Microbiology, Washington, DC.
5. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA.
6. Armitage, P. & Berry, G. (1994). Statistical Methods in Medical Research, 3rd edn. Blackwell Scientific Publications, Oxford.
7. Hachem, C. Y., Clarridge, J. E., Reddy, R., Flamm, R., Evans, D. G., Tanaka, S. K. et al. (1996). Antimicrobial susceptibility of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagnostic Microbiology and Infectious Disease 24, 37-41.
8. Goddard, A. F. & Logan, R. P. H. (1996). Antimicrobial resistance and Helicobacter pylori. Journal of Antimicrobial Chemotherapy 37, 639-43.
9. Maton, P. N. (1991). Omeprazole. New England Journal of Medicine 324, 965-75.
10. Versalovic, J., Kibler, K., Small, S., Hachem, C. Y., Graham, D. Y. & Go, M. F. (1995). Molecular basis of clarithromycin resistance in Helicobacter pylori. Gastroenterology 108, A251.